PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-14.98%
Both yoy net incomes decline, with ORCL at -0.20%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-0.39%
Both reduce yoy D&A, with ORCL at -3.96%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-19.43%
Negative yoy deferred tax while ORCL stands at 34.78%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
1.26%
SBC growth while ORCL is negative at -2.50%. John Neff would see competitor possibly controlling share issuance more tightly.
74.83%
Well above ORCL's 51.46% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
208.20%
AR growth well above ORCL's 107.79%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-140.19%
Both reduce yoy inventory, with ORCL at -2400.00%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-384.67%
Both negative yoy AP, with ORCL at -251.10%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
7.70%
Lower 'other working capital' growth vs. ORCL's 60.30%. David Dodd would see fewer unexpected short-term demands on cash.
3.43%
Well above ORCL's 5.41%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
120.51%
Operating cash flow growth similar to ORCL's 113.09%. Walter Schloss would see parallel improvements or market conditions in cash generation.
6.64%
Some CapEx rise while ORCL is negative at -63.56%. John Neff would see competitor possibly building capacity while we hold back expansions.
94.20%
Acquisition spending well above ORCL's 78.17%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
-57.66%
Negative yoy purchasing while ORCL stands at 18.80%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
43.94%
We have some liquidation growth while ORCL is negative at -22.09%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-240.34%
Both yoy lines negative, with ORCL at -4.12%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-16.22%
We reduce yoy invests while ORCL stands at 61.12%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-37.04%
We cut debt repayment yoy while ORCL is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
20.66%
Lower share issuance yoy vs. ORCL's 74.84%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
-139.21%
We cut yoy buybacks while ORCL is 4.55%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.